J. Safra Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.25K Buy
26
+6
+30% +$575 ﹤0.01% 594
2025
Q4
$1.92K Hold
20
﹤0.01% 575
2025
Q3
$1.91K Buy
+20
New +$1.84K ﹤0.01% 415
2023
Q1
Sell
-217
Closed -$16K 118
2022
Q4
$16K Buy
+217
New +$17.6K ﹤0.01% 48
2022
Q2
Sell
-146
Closed -$1K 98
2022
Q1
$1K Buy
+146
New +$15.4K 0.02% 39

Other funds holding MDT

J. Safra Asset Management's MDT Position: Q1 2026 in Review

J. Safra Asset Management increased its Medtronic (MDT) stake by 30% in Q1 2026, buying an estimated $575 and bringing the position to 26 shares worth $2.25K. The position accounts for ﹤0.01% of the portfolio, ranked #594.

J. Safra Asset Management first reported a position in MDT in Q1 2022 and has held it in 5 quarters since. The position peaked at $16K in Q4 2022. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • J. Safra Asset Management held 26 shares of Medtronic worth $2.25K as of Q1 2026.
  • J. Safra Asset Management bought 6 Medtronic shares in Q1 2026, an estimated $575.
  • Medtronic made up ﹤0.01% of J. Safra Asset Management's portfolio in Q1 2026, its #594 holding.
  • J. Safra Asset Management first reported a position in Medtronic in Q1 2022 and has held it in 5 quarters since.
  • J. Safra Asset Management's Medtronic position peaked at $16K in Q4 2022.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on J. Safra Asset Management's 13F filing for Q1 2026, filed 4 May 2026.